BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/12/2014 11:15:00 AM | Browse: 783 | Download: 664
Publication Name World Journal of Pharmacology
Manuscript ID 11441
Country/Territory United Kingdom
Received
2014-05-21 21:14
Peer-Review Started
2014-05-21 22:45
To Make the First Decision
2014-06-06 11:00
Return for Revision
2014-06-16 11:36
Revised
2014-07-14 19:48
Second Decision
2014-10-27 16:58
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-10-27 17:17
Articles in Press
2014-10-27 17:17
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-11-28 17:54
Publish the Manuscript Online
2014-12-12 11:14
ISSN 2220-3192 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Systematic Reviews
Article Title Association of serum bilirubin and non-alcoholic fatty liver disease: a feasible therapeutic avenue?
Manuscript Source Invited Manuscript
All Author List Mohamed S Anwar, John F Dillon and Michael H Miller
Funding Agency and Grant Number
Corresponding Author Dr. Mohamed Anwar, Gut Group, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Nethergate, Dundee DD1 9SY, United Kingdom. mohamed-anwar@doctors.org.uk
Key Words Review; Systematic; Bilirubin; Hyperbilirubinemia; Anti-oxidants; Adult; Non-alcoholic fatty liver disease
Core Tip This systematic review summarises and highlights the deficiencies in the current studies on the association of serum bilirubin with non-alcoholic fatty liver disease (NAFLD). It explores the potential underpinning of the mechanistic association of NAFLD with bilirubin. Potential novel therapeutic avenues of bilirubin are explored in NAFLD, a common condition with oxidative damage as a core pathogenetic factor. Although this area of study is still in its infancy, this review is a timely summary of current key studies in this subject area and provides an up to date thought perspective with focus on future direction and potential therapeutic application.
Publish Date 2014-12-12 11:14
Citation Anwar MS, Dillon JF, Miller MH. Association of serum bilirubin and non-alcoholic fatty liver disease: A feasible therapeutic avenue? World J Pharmacol 2014; 3(4): 209-216
URL http://www.wjgnet.com/2220-3192/full/v3/i4/209.htm
DOI http://dx.doi.org/10.5497/wjp.v3.i4.209
Full Article (PDF) WJP-3-209.pdf
Full Article (Word) WJP-3-209.doc
Manuscript File 11441-Review.docx
Answering Reviewers 11441-Answering reviewers.pdf
Copyright License Agreement 11441-Copyright assignment.pdf
Peer-review Report 11441-Peer review(s).pdf
Scientific Misconduct Check 11441-CrossCheck.jpg
Scientific Editor Work List 11441-Scientific editor work list.pdf